Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Issuance of Common Stock

Acadia Pharmaceutica Issuance of Common Stock Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Issuance of Common Stock from 2010 to 2020.
  • Acadia Pharmaceutica Issuance of Common Stock for the quarter ending June 06, 2020 was $47m a -575.02% decrease of -273m year over year
  • Acadia Pharmaceutica Issuance of Common Stock for the last 12 months ending June 06, 2020 was $414m a -51.96% decrease of -215m year over year
  • Acadia Pharmaceutica Annual Issuance of Common Stock for 2019 was $372m a 17.53% increase of 65m from 2018
  • Acadia Pharmaceutica Annual Issuance of Common Stock for 2018 was $307m a 89.83% increase of 275m from 2017
  • Acadia Pharmaceutica Annual Issuance of Common Stock for 2017 was $31m a -1,609.68% decrease of -502m from 2016
Other Cash Flow Metrics:
  • Acadia Pharmaceutica Cash Flow from Operations for the quarter ending September 09, 2018 was $-42m a 29.29% decrease of -12m year over year
  • Acadia Pharmaceutica Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-22m a 80.38% decrease of -17m year over year
  • Acadia Pharmaceutica Total Revenue for the quarter ending September 09, 2018 was $58m a 25.29% increase of 15m year over year
View Chart On Koyfin

Quarterly ACAD Issuance of Common Stock Data

06/2020$47m
03/2020$4m
12/2019$43m
09/2019$320m
06/2019$5m
03/2019$4m
12/2018$301m
09/2018$0m
06/2018$3m
03/2018$3m

Annual ACAD Issuance of Common Stock Data

2019$372m
2018$307m
2017$31m
2016$533m
2015$15m
2014$204m
2013$112m
2012$98m
2011$14m
2010$1m